| Mr Stephen Koty Price, AA-C | |
|
211 Landing Rd Apt C, North Myrtle Beach, SC 29582-2999 | |
| (843) 845-7619 | |
| Not Available |
| Full Name | Mr Stephen Koty Price |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 10 Years |
| Location | 211 Landing Rd Apt C, North Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841608155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Secondary |
| 367H00000X | Anesthesiologist Assistant | AA43 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand Strand Regional Medical Center | Myrtle beach, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlantic Coast Anesthesia Services Pc | 3971887167 | 90 |
News Archive
People who have undergone obesity (bariatric) surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with the general population, however, both groups' excess mortality is high.
On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.
Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood.
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 9 days ago
| Entity Name | Coastal Anesthesia Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609813179 PECOS PAC ID: 1850295650 Enrollment ID: O20031124000145 |
News Archive
People who have undergone obesity (bariatric) surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with the general population, however, both groups' excess mortality is high.
On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.
Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood.
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 9 days ago
| Entity Name | Beach Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215061429 PECOS PAC ID: 6103924014 Enrollment ID: O20070530000620 |
News Archive
People who have undergone obesity (bariatric) surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with the general population, however, both groups' excess mortality is high.
On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.
Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood.
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 9 days ago
| Entity Name | Atlantic Coast Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932641313 PECOS PAC ID: 3971887167 Enrollment ID: O20170308000291 |
News Archive
People who have undergone obesity (bariatric) surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with the general population, however, both groups' excess mortality is high.
On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.
Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood.
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 9 days ago
| Entity Name | Anesthesia Sc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295271948 PECOS PAC ID: 6800172453 Enrollment ID: O20170413000961 |
News Archive
People who have undergone obesity (bariatric) surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with the general population, however, both groups' excess mortality is high.
On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.
Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood.
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Stephen Koty Price, AA-C 211 Landing Rd Apt C, North Myrtle Beach, SC 29582-2999 Ph: (843) 845-7619 | Mr Stephen Koty Price, AA-C 211 Landing Rd Apt C, North Myrtle Beach, SC 29582-2999 Ph: (843) 845-7619 |
News Archive
People who have undergone obesity (bariatric) surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with the general population, however, both groups' excess mortality is high.
On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.
Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood.
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
› Verified 9 days ago